» Articles » PMID: 35715478

Elevated Expression of TLR2 and Its Correlation with Disease Activity and Clinical Manifestations in Adult-onset Still's Disease

Overview
Journal Sci Rep
Specialty Science
Date 2022 Jun 17
PMID 35715478
Authors
Affiliations
Soon will be listed here.
Abstract

This study investigated the role of Toll-like receptor 1 (TLR1), TLR2, TLR4, TLR7, and TLR9 in patients with adult-onset Still's disease (AOSD). This study included 20 patients with AOSD and 15 healthy controls (HCs). TLR expression in the peripheral blood was quantified using flow cytometry; TLR expression pattern, in the skin lesions and lymph nodes (LNs) of patients with AOSD, was evaluated immunohistochemically. Significantly higher mean intensities of cells presenting TLR2 and TLR7 from whole blood were observed in patients with AOSD than in HCs. TLR2 expression in whole cells correlated with systemic scores, levels of lactate dehydrogenase and ferritin and serum levels of interleukin-1β (IL-1β), IL-6, and IL-18. The percentage of TLR2-positive inflammatory cells was higher in skin biopsy samples from patients with AOSD than those in HCs. TLR9-expressing positive inflammatory cell counts were higher in skin lesions from patients with AOSD than those in the HC, eczema, and psoriasis groups. The expression levels of TLR1, TLR4, TLR7, and TLR9 were higher in LNs of patients with AOSD than in those with T cell lymphoma and reactive lymphadenopathy. Circulating TLR2- and TLR7-positive cells may contribute to the pathogenesis of AOSD. Furthermore, immunohistochemical staining for TLRs in skin lesions and LNs may aid in differentiating AOSD from similar conditions.

Citing Articles

Adult-Onset Still's Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options.

Bindoli S, Baggio C, Doria A, Sfriso P Drugs. 2024; 84(3):257-274.

PMID: 38441807 PMC: 10982104. DOI: 10.1007/s40265-024-01993-x.

References
1.
Kim H, Choi B, Suh C, Han M, Jung J, Sayeed H . Highly Expression of CD11b and CD32 on Peripheral Blood Mononuclear Cells from Patients with Adult-Onset Still's Disease. Int J Mol Sci. 2017; 18(1). PMC: 5297832. DOI: 10.3390/ijms18010202. View

2.
Raschi E, Chighizola C, Cesana L, Privitera D, Ingegnoli F, Mastaglio C . Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts. Arthritis Res Ther. 2018; 20(1):187. PMC: 6116570. DOI: 10.1186/s13075-018-1689-6. View

3.
Raschi E, Privitera D, Bodio C, Lonati P, Borghi M, Ingegnoli F . Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis. Arthritis Res Ther. 2020; 22(1):265. PMC: 7654597. DOI: 10.1186/s13075-020-02360-3. View

4.
Ferwerda G, Meyer-Wentrup F, Kullberg B, Netea M, Adema G . Dectin-1 synergizes with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophages. Cell Microbiol. 2008; 10(10):2058-66. DOI: 10.1111/j.1462-5822.2008.01188.x. View

5.
Kuusela E, Kouri V, Olkkonen J, Koivuniemi R, Ayravainen L, Rajamaki K . Serum Epstein-Barr virus DNA, detected by droplet digital PCR, correlates with disease activity in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2018; 36(5):778-784. View